These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 24764226)

  • 21. [The prognostic value of cytokeratin 19 expression in non-small cell lung cancer].
    Kosacka M; Jankowska R
    Pneumonol Alergol Pol; 2007; 75(4):317-23. PubMed ID: 18080980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitive detection of small cell lung carcinoma cells by reverse transcriptase-polymerase chain reaction for prepro-gastrin-releasing peptide mRNA.
    Saito T; Kobayashi M; Harada R; Uemura Y; Taguchi H
    Cancer; 2003 May; 97(10):2504-11. PubMed ID: 12733150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bronchogenic carcinoma and secondary aspergillosis--common yet unexplored: evaluation of the role of bronchoalveolar lavage-polymerase chain reaction and some nonvalidated serologic methods to establish early diagnosis.
    Shahid M; Malik A; Bhargava R
    Cancer; 2008 Aug; 113(3):547-58. PubMed ID: 18521930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor Cell Malignant Properties Are Enhanced by Circulating Exosomes in Sleep Apnea.
    Almendros I; Khalyfa A; Trzepizur W; Gileles-Hillel A; Huang L; Akbarpour M; Andrade J; Farré R; Gozal D
    Chest; 2016 Nov; 150(5):1030-1041. PubMed ID: 27568581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical usefulness of a new tumor marker CYFRA21-1 in patients with lung cancer].
    Li R; Li R; Wang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jan; 21(1):26-9. PubMed ID: 11263296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer.
    Kotsinas A; Evangelou K; Sideridou M; Kotzamanis G; Constantinides C; Zavras AI; Douglass CW; Papavassiliou AG; Gorgoulis VG
    Cancer Lett; 2008 Feb; 259(2):177-85. PubMed ID: 18037232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A correlative study of bronchial cytology, bronchoalveolar lavage (BAL) and serum tumor markers in the diagnosis of lung carcinoma.
    Nikliński J; Chyczewski L; Chyczewska E; Laudański J; Furman M
    Folia Histochem Cytobiol; 1993; 31(4):211-3. PubMed ID: 8138002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of CEA and SCC-Ag in bronchoalveolar lavage (BAL) and serum of patients with lung carcinoma.
    Nikliński J; Chyczewska E; Furman M; Kowal E; Kozłowski M
    Neoplasma; 1992; 39(5):283-5. PubMed ID: 1331827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteomic analysis of resectable non-small cell lung cancer: post-resection serum samples may be useful in identifying potential markers.
    Rathinam S; Ward DG; James ND; Rajesh PB
    Interact Cardiovasc Thorac Surg; 2011 Jul; 13(1):3-6. PubMed ID: 21525028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomarkers and IL-2R in lung cancer.
    Marino P; Preatoni A; Fonticoli L; Parodi M; Tarolo GL
    Recenti Prog Med; 1990 Nov; 81(11):702-4. PubMed ID: 1962891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High serum concentrations of Sialyl Lewisx predict multilevel N2 disease in non-small-cell lung cancer.
    Mizuguchi S; Inoue K; Iwata T; Nishida T; Izumi N; Tsukioka T; Nishiyama N; Uenishi T; Suehiro S
    Ann Surg Oncol; 2006 Jul; 13(7):1010-8. PubMed ID: 16788764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Bronchial cancer and asbestos: comparison of anamnestic exposure to asbestos, detection of asbestos bodies in bronchoalveolar lavage and in lung tissue].
    Schildge J; Pumpe K; Ortlieb H; Costabel U
    Pneumologie; 1990 Feb; 44 Suppl 1():333-4. PubMed ID: 2164195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.
    Ando S; Kimura H; Iwai N; Shima M; Ando M; Kuriyama T
    Anticancer Res; 2001; 21(4B):3085-92. PubMed ID: 11712815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The assessment of acute phase proteins as prognostic factors in patients surgically treated for non-small cell lung cancer].
    Kasprzyk M; Dyszkiewicz W; Zwaruń D; Leśniewska K; Wiktorowicz K
    Pneumonol Alergol Pol; 2008; 76(5):321-6. PubMed ID: 19003761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum protein expression predicts recurrence in patients with early-stage lung cancer after resection.
    D'Amico TA; Brooks KR; Joshi MB; Conlon D; Herndon J; Petersen RP; Harpole DH
    Ann Thorac Surg; 2006 Jun; 81(6):1982-7; discussion 1987. PubMed ID: 16731117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical analysis of tissue localization of cytokeratin 19 in lung cancer.
    Chyczewski L; Nikliński J; Chyczewska E; Laudański J; Furman M
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():162-72. PubMed ID: 9337534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical utility of hyaluronic acid values in serum and bronchoalveolar lavage fluid as tumor marker for bronchogenic carcinoma.
    Hernández Hernández JR; García García JM; Martínez Muñíz MA; Allende Monclus MT; Ruibal Morell A
    Int J Biol Markers; 1995; 10(3):149-55. PubMed ID: 8551057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induced sputum and bronchoalveolar lavage as tools for evaluating the effects of inhaled corticosteroids in patients with asthma.
    Nocker RE; Out TA; Weller FR; de Riemer MJ; Jansen HM; van der Zee JS
    J Lab Clin Med; 2000 Jul; 136(1):39-49. PubMed ID: 10882226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification.
    Díaz-García CV; Agudo-López A; Pérez C; López-Martín JA; Rodríguez-Peralto JL; de Castro J; Cortijo A; Martínez-Villanueva M; Iglesias L; García-Carbonero R; Fresno Vara JA; Gámez-Pozo A; Palacios J; Cortés-Funes H; Paz-Ares L; Agulló-Ortuño MT
    Carcinogenesis; 2013 May; 34(5):1031-8. PubMed ID: 23349018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between the miRNA signatures in plasma and bronchoalveolar fluid in respiratory pathologies.
    Molina-Pinelo S; Suárez R; Pastor MD; Nogal A; Márquez-Martín E; Martín-Juan J; Carnero A; Paz-Ares L
    Dis Markers; 2012; 32(4):221-30. PubMed ID: 22430188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.